quinazolines has been researched along with Urinary Bladder, Overactive in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Ahn, JH; Bae, EJ; Cho, S; Jo, H; Kim, SJ; Kwon, JW; Lee, N; Park, CS | 1 |
Cho, HJ; Cho, JM; Kang, JY; Moon, HS; Seo, DY; Shin, SC; Sung, LH; Yoo, TK; Yu, JH | 1 |
Cho, KJ; Kim, JC | 1 |
Arunkalaivanan, A; Sinha, D | 1 |
Benemei, S; Geppetti, P; Materazzi, S; Nassini, R | 1 |
2 review(s) available for quinazolines and Urinary Bladder, Overactive
Article | Year |
---|---|
Alfuzosin for the treatment of storage symptoms suggestive of overactive bladder.
Topics: Adrenergic alpha-Antagonists; Animals; Humans; Quinazolines; Urinary Bladder, Overactive | 2012 |
The concept of neurogenic inflammation.
Topics: Adrenergic alpha-Antagonists; Animals; Calcium Channels; Humans; Male; Nerve Tissue Proteins; Neurogenic Inflammation; Prostatism; Prostatitis; Quinazolines; Rats; Transient Receptor Potential Channels; TRPA1 Cation Channel; TRPV Cation Channels; Urinary Bladder; Urinary Bladder, Overactive | 2008 |
1 trial(s) available for quinazolines and Urinary Bladder, Overactive
Article | Year |
---|---|
Comparison of alfuzosin 10 mg with or without propiverine 10 mg, 20 mg in men with lower urinary tract symptom and an overactive bladder: randomised, single-blind, prospective study.
Topics: Benzilates; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prospective Studies; Quinazolines; Single-Blind Method; Treatment Outcome; Urinary Bladder, Overactive; Urological Agents | 2014 |
2 other study(ies) available for quinazolines and Urinary Bladder, Overactive
Article | Year |
---|---|
Discovery and characterization of a potent activator of the BK
Topics: Animals; Membrane Potentials; Muscle Relaxation; Myocytes, Smooth Muscle; Quinazolines; Rats; Urinary Bladder, Overactive | 2022 |
Urethral syndrome: response to alpha-adrenergic blocking agents.
Topics: Adrenergic alpha-Antagonists; Adult; Depression; Female; Humans; Quinazolines; Remission Induction; Sulfonamides; Syndrome; Tamsulosin; Urinary Bladder, Overactive | 2006 |